25-OCT-2025 6:10

ERLYTX ACCRUAL REPORT - Open and Recently Closed Studies

SWOG/
Support
STUDY R
E
G
O
P
E
N
ARM ACCR.
GOAL
TOTAL
REGS.
REGS.
LAST
12
Month
REGS.
LAST
6
Month
REGS.
LAST
3
Month
REGS.
LAST
30
DAYS
REGS.
LAST
7
DAYS
DATE OF
FIRST
REG.
# of
ACT.
INSTs
# of
CURR
IRBs
SWOG S2012-Extrapulm NEC, Stg IV, Combo Chemo +/- Atezo 1 Y 1 Platinum/Etoposide + Atezo Induction + Maintenance 189 45 23 10 4 2 0 06/28/2022 249 77
        2 Platinum/Etoposide + Atezo Induction   40 19 9 6 2 1      
        3 Platinum/Etoposide Only   40 21 10 7 2 1      
            125 63 29 17 6 2      
 
  EAY191-S3-ComboMATCH: Adv Solid Tumors, Pac+Ipatasertib 1 Y 1 Paclitaxel + Ipatasertib 33 32 28 12 7 0 0 09/22/2023 198 66
            32 28 12 7 0 0      
 
Yes A071401-Prog Meningiomas,SMO/AKT/NF2 Inhib 0 E Total Registrations   52 4 2 2 0 0 02/22/2016 267 82
            52 4 2 2 0 0      
 
    1 E Total Registrations   9 1 1 1 1 0 02/22/2016    
            9 1 1 1 1 0      
 
No AGCT1531-Mult, Stg I-IV, Carbo vs Cisp, Ped &Adult 1 E Total Registrations   4 2 1 1 1 0 10/07/2021 189 115
            4 2 1 1 1 0      
 
  EAY191-ComboMATCH 1 E Total Registrations   20 10 7 3 0 0 08/03/2023 329 125
            20 10 7 3 0 0      
 

25-OCT-2025 6:10

ERLYTX Open Studies with No Registrations

Study Registration/Phase Open Date # of
ACT.
INSTs
# of
CURR
IRBs
AGCT1531 Mult, Stg I-IV, Carbo vs Cisp, Ped &Adult 2 Late Randomization Callback 08-May-17 189 115
EAY191 ComboMATCH 2 Re-Screening 06-Mar-23 329 125